CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.72
−0.90%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $53.3M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- $0.29
- EPS estimate
- $0.24
- Revenue actual
- $101.9M
- Revenue estimate
- $96.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +9.6%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $14
- PT range
- $14 – $14
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | $0.24 | $0.29 | Beat 21.85% | $101.9M |
| May 14, 2026 | $0.35 | $0.43 | Beat 22.86% | $127.4M |
| Mar 5, 2026 | $0.82 | $0.61 | Miss -25.25% | $128.6M |
| Nov 12, 2025 | $0.48 | $0.57 | Beat 18.75% | $104.3M |
| Aug 7, 2025 | $0.20 | $0.28 | Beat 40.00% | $39.7M |
| Mar 25, 2025 | $0.17 | $0.22 | Beat 29.41% | $31.2M |
| Aug 14, 2024 | -$0.26 | -$0.25 | Beat 3.85% | $806.1K |
| May 9, 2024 | -$0.27 | -$0.25 | Beat 7.41% | — |
| Mar 12, 2024 | -$0.21 | -$0.26 | Miss -23.81% | $304.1K |
| Nov 14, 2023 | -$0.21 | -$0.17 | Beat 19.05% | — |
| May 15, 2023 | -$0.20 | -$0.24 | Miss -20.00% | — |
| Nov 10, 2022 | -$0.23 | -$0.17 | Beat 26.09% | $6.8K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026